Clinical Trial Update: Platelet Hyperreactivity to Aspirin and Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining platelet hyperreactivity to aspirin and its relation to stroke outcomes. The study touches broader vascular conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Cerebral Infarction
• Coronary Syndrome
• Ischemia
• Stroke
• Thrombosis

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Stroke, Cerebral Infarction | Phase 4 | Status: COMPLETED